LONDON, UK and VANCOUVER, BC/ ACCESSWIRE / December 29, 2022 / Mkango Resources Ltd. (AIM:MKA)(TSX-V:MKA) (the "Company" or "Mkango") and CoTec Holdings Corp. (TSX-V:CTH) ("CoTec") are pleased to provide an update on the transaction announced on 30 May 2022 (the "Transaction"). CoTec has advanced a further £325,000 to Mkango by way of a convertible advance note (the "Advance") and Mkango has extended exclusivity until January 31, 2023. The terms of the Advance are consistent with the terms of the advance that CoTec provided to Mkango in October 2022. The conversion rights associated with the Advance remain subject to TSX Venture Exchange approval.
Market Abuse Regulation (MAR) Disclosure
Theinformation contained withinthis announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations(EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publicationof this announcementvia Regulatory Information Service, this inside information is now considered to be in the public domain.
About Mkango Resources Limited
Mkango's corporate strategy is to develop new sustainable primary and secondary sources of neodymium, praseodymium, dysprosium and terbium to supply accelerating demand from electric vehicles, wind turbines and other clean technologies. This integrated Mine, Refine, Recycle strategy differentiates Mkango from its peers, uniquely positioning the Company in the rare earths sector.
Mkango is developing Songwe Hill in Malawi with a Feasibility Study completed in July 2022. Malawi is known as "The Warm Heart of Africa", a stable democracy with existing road, rail and power infrastructure, and new infrastructure developments underway.
In parallel, Mkango and Grupa Azoty PULAWY, Poland's leading chemical company and the second largest manufacturer of nitrogen and compound fertilizers in the European Union, have agreed to work together towards development of a rare earth Separation Plant at Pulawy in Poland (the "Pulawy Separation Plant"). The Pulawy Separation Plant will process the purified mixed rare earth carbonate produced at Songwe Hill.
Through its ownership of Maginito (www.maginito.com), Mkango is also developing green technology opportunities in the rare earths supply chain, encompassing neodymium (NdFeB) magnet recycling as well as innovative rare earth alloy, magnet, and separation technologies. Maginito holds a 42% interest in UK rare earth (NdFeB) magnet recycler, HyProMag (www.hypromag.com) with an option to increase its interest to 49%.
Mkango also has an extensive exploration portfolio in Malawi, including the Mchinji rutile exploration project, the Thambani uranium-tantalum-niobium-zircon project and Chimimbe nickel-cobalt project.
For more information, please visit www.mkango.ca
About CoTec Holdings Corp.
CoTec is a publicly traded investment issuer listed on the Toronto Venture Stock Exchange ("TSX-V") and trades under the symbol CTH.V. The Company is an ESG-focused company investing in innovative technologies that have the potential to fundamentally change the way metals and minerals can be extracted and processed for the purpose of applying those technologies to undervalued operating assets and recycling opportunities, as the Company seeks to transition into a mid-tier mineral resource producer.
For more information, please visit www.cotec.ca.
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements (within the meaning of that term under applicable securities laws) with respect to Mkango, and CoTec. Generally, forward looking statements can be identified by the use of words such as "plans", "expects" or "is expected to", "scheduled", "estimates" "intends", "anticipates", "believes", or variations of such words and phrases, or statements that certain actions, events or results "can", "may", "could", "would", "should", "might" or "will", occur or be achieved, or the negative connotations thereof. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. Such factors and risks include, without limiting the foregoing, completion of the Transactions, governmental action relating to COVID-19, COVID-19 and other market effects on global demand and pricing for the metals and associated downstream products for which Mkango is exploring, researching and developing, factors relating the development of the Mkango UK Pilot Plant, the Pulawy Separation Plant, including the outcome and timing of the completion of the feasibility studies, cost overruns, complexities in building and operating the Separation Plant, changes in economics and government regulation, the positive results of a feasibility study on the Pulawy Separation Plant and Songwe and delays in obtaining financing or governmental approvals for, and the impact of environmental and other regulations relating to, Songwe, the Mkango UK Pilot Plant and the Pulawy Separation Plant. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company and CoTec disclaim any intention and assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Additionally, the Company and CoTec undertake no obligation to comment on the expectations of, or statements made by, third parties in respect of the matters discussed above.
For further information on Mkango, please contact:
Mkango Resources Limited
William Dawes Alexander Lemon
Chief Executive Officer President
Canada: +1 403 444 5979
Financial Public Relations
UK: +44 207 138 3204
SP Angel Corporate Finance LLP
Nominated Adviser and Joint Broker
Jeff Keating, Caroline Rowe
UK: +44 20 3470 0470
Alternative Resource Capital
Alex Wood, Keith Dowsing
UK: +44 20 7186 9004/5
For further information on CoTec, please contract:
CoTec Holdings Corp.
Chief Financial Officer
Canada: +1 604 992-5600
The TSX Venture Exchange has neither approved nor disapproved the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any equity or other securities of the Company in the United States. The securities of the Company will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and may not be offered or sold within the United States to, or for the account or benefit of, U.S. persons except in certain transactions exempt from the registration requirements of the U.S. Securities Act.
SOURCE: CoTec Holdings Corp.
View source version on accesswire.com:
The FDA accepts Kala Pharmaceuticals' (KALA) investigational new drug application for pipeline candidate KPI-012 for treating persistent corneal epithelial defect. Stock up.
In this article, we will take a look at the 11 best buy-the-dip stocks to buy now. If you want to see more stocks in this selection, go to the 5 Best Buy-the-Dip Stocks To Buy Now. The leading US market indices are on their way to recording the first annual loss since 2018 and the […]
The Dow Jones rallied Thursday after first-time jobless claims. Tesla stock raced higher on a reiterated overweight rating.
Investors have been trying to get excited about the possibility for a stock market turnaround in 2023, but much of the week between holidays has shown how downbeat Wall Street is right now about market prospects. Futures on major market benchmarks were all higher in premarket trading, with the Nasdaq Composite (NASDAQINDEX: ^IXIC) seeing the most significant gains, rising three-quarters of a percent. As it turns out, what Cal-Maine said gives an interesting view into the situation that many consumer-facing businesses are currently experiencing as they make plans for 2023.
The Oracle of Omaha's preferred length of time to hold an investment is "forever" — which is quite a long holding period. It's perfectly fine to consider following Buffett into a couple of his stock positions as long as you're willing to be as patient as he is and refrain from selling for quite some time. Johnson & Johnson (NYSE: JNJ) only accounts for around 0.02% of Buffett's portfolio, but it's a strong example of how and why his investing strategy is successful over time.
All three of these high-yield dividend stocks have a long history of annual payout raises and an ability to raise their distributions without breaking their balance sheets. Shares of AbbVie (NYSE: ABBV) have risen more than 50% from a low point in October. Right now, AbbVie's dividend doesn't offer much more than a savings account.
In this article, we will take a look at the 12 best 52-week high stocks to buy now. If you want to see more stocks in this selection, go to the 5 Best 52-Week High Stocks To Buy Now. The equity markets have been taking a beating this year as the Dow Jones Industrial Average […]
Economic uncertainty has hit the S&P 500 like a wrecking ball this year, sending the benchmark index spiraling into a bear market. Its share price has plummeted 72% year to date, which makes it the second-worst-performing stock in the S&P 500. For context, Tesla has never suffered a sharper share price decline at any point in its history, and six analysts have downgraded the stock in the last two weeks alone.
Stock markets would like to just get there without any more meaningful losses, says Navellier and Associate’s chairman and founder Louis Navellier, who adds that “anyone who made bets for a big rally this week is probably folding their tent.” The stock closed at a fresh 52-week low today [Wednesday] as it sliced through key support around $130.
The shares currently trade at 13x 2023 consensus earnings estimates, which is actually not all that far out of line from where INTC has traded over the past several years. Bolstering the story here is Intel's 36.5 cent quarterly dividend, which equates to a healthy 5.6% yield. Intel has somewhat quietly become a dividend champion over the years, and has raised it at an 8.1% compound annual growth rate (CAGR) over the past 15 years.
These stocks won't crumble under the pressure of an economic recession if there is one next year.
Investors are understandably curious about Upstart (NASDAQ: UPST) stock after the price has fallen considerably. This video will determine if Upstart's stock is a buy heading into 2023. *Stock prices used were the afternoon prices of Dec.
My children have inherited $5 million of stock from their father (whose estate has not yet been dispersed after 11 months) leaving them with a 30% or so loss of value over which they have had no control. Is there … Continue reading → The post Ask an Advisor: My Kids Inherited $5 Million. How Should They Handle It? appeared first on SmartAsset Blog.
In an email sent to staff on Wednesday and reviewed by Reuters, Musk said he believes that long term, Tesla will be the most valuable company on earth. He also urged employees to ramp up deliveries at the end of this quarter, after the automaker offered discounts on its vehicles in the United States and China.
Electric-car maker Tesla (NASDAQ: TSLA) is set to report deliveries for its fourth quarter early next week. The company usually reports quarterly deliveries a few days after the calendar quarter ends, so Tesla will provide an update on fourth-quarter deliveries on Monday. With Tesla shareholders getting battered and bruised this year, the report next week will likely have a lot of eyes on it.
In its life as a public company, Snowflake (NYSE: SNOW) has proliferated — its revenue is up 362% since late 2020 — yet the stock is down 42% from its IPO date. While Snowflake's growth and price decline are facts, there's a missing piece: valuation. At 23 times sales, Snowflake's stock is still expensive, but its growth makes the valuation palatable.
While the stock market may be trading down across sectors and indices right now, the long-term growth potential remains for wonderful companies with high-quality businesses. Investing in stocks that can enrich your portfolio over the long-term doesn't always mean you need to find the most exciting of businesses. Johnson & Johnson (NYSE: JNJ) is a perfect example of a "boring" stock that has established an incredible track record of growth and enriched investors time and time again throughout the years.
Ford Motor Company (F) closed at $11.20 in the latest trading session, marking a -1.41% move from the prior day.
Egg prices have been on the rise as rapid inflation hits grocery store aisles. The largest U.S. egg producer on Wednesday said its quarterly sales more than doubled from those of the same period last year as rapid inflation and the effects from an avian-influenza outbreak pushed prices higher. Cal-Maine’s net average selling price per dozen eggs for the three months ended Nov. 26 was $2.88, up from $2.37 in the prior quarter and $1.15 a year earlier, the company said.
In the latest trading session, Silvergate Capital Corporation (SI) closed at $15.98, marking a +1.33% move from the previous day.